Global X ETFs Announces the Release of its Third Annual 'Charting Disruption' Thematic Outlook for 2024 and Beyond

NEW YORK, Dec. 11, 2023 /PRNewswire/ -- Global X ETFs, the New York-based provider of exchange-traded funds (ETFs), today announced the launch of Charting Disruption 2024, its third annual landmark research project that aims to shed a quantifiable light on what the future may hold. Global X partnered with handpicked experts in fields such as Artificial Intelligence, Digital Assets, CleanTech, Autonomous Vehicles, Genomics & Biotech, and Food Innovation to unpack the breakthrough trends, cutting-edge technologies and real-world applications covered in this year's interactive outlook.

"It can be challenging to envision the capacity for global change within a lifetime, but with Charting Disruption we strive to do just that," commented Pedro Palandrani, Director of Research at Global X. "As a leader in thematic investing, we are committed to providing clients and investors with the resources needed to understand and leverage the trends shaping our economy. This year's project focuses on the interplay between technology and emerging areas of innovation in green energy, artificial intelligence, healthcare, and more. We take you with us to have a closer look at the breakthroughs we're witnessing around the world. From riding in an autonomous truck with Kodiak, the company leading the charge in self-driving trucks, to touring a solar farm and seeing first-hand the positive impact of fiscal policies in the transition to net zero, we believe the possibilities are endless."

Charting Disruption 2024 looks back at the inventions of yesterday to forecast the changes we anticipate tomorrow. Through analyses, interviews, video explorations, charts and more, Charting Disruption reveals what we expect to disrupt our world in 2024 and beyond.

Key Insights:

• CleanTech: Expert consensus suggests the world must limit global warming to 1.5–2.0 degrees Celsius to avoid the worst impacts of climate change, which will require an estimated $150 trillion in investments from 2023–2050 across all energy transition technologies.[i]
• Electric Vehicles: Annual global EV sales are anticipated to rise from 10 million in 2022 to nearly 70 million by 2035,[ii] magnifying demand for several minerals, including graphite and lithium.
• U.S. Infrastructure: After years of stagnation, a new era of industrial production growth is materializing. U.S. construction spending on manufacturing has outpaced growth in other segments since the beginning of the COVID-19 pandemic and reached a record $108 billion in 2022.[iii]
• Artificial Intelligence: Rapid advancements in artificial intelligence could add $16 trillion to the global economy by 2030.[iv]
• Cloud Computing: With the rise of AI, increasing demand for cloud solutions is fueling the need for more powerful processors in greater quantities. A $26 billion industry today, the AI chipset market is expected to grow to an estimated $175 billion by 2030.[v]
• Robotics: Estimates expect the average cost of industrial robots to decline 85% from 2005 to 2030. As industrial robots become more affordable and technologically sophisticated, their adoption will increase across various industries.[vi]
• FinTech: As consumers turn to payment apps and other mobile banking solutions, global FinTech revenues are forecast to surge from $245 billion in 2021 to $1.5 trillion in 2030, disrupting adjacent segments, like insurance.[vii]
• Digital Experiences: Of the roughly $200 billion in projected spending on video games in 2023, PCs, smartphones and virtual reality devices account for approximately 85% of the total, shifting away from the hardware-and-console-driven environment of the past. [viii]
• Genomics: While much of today's gene-sequencing market is focused on the early diagnosis of cancer and neurological disorders, there are emerging use cases in clinical areas, such as disease testing and reproductive health. Accordingly, sequencing market revenues of $8.4 billion in 2023 are forecast to double by 2027.[ix]
• Therapeutics: The weight management market is expected to be worth over $100 billion by the end of the decade, up from $2.8 billion today.[x] Global obesity rates have nearly tripled since 1975, increasing prevalence rates for related disorders.[xi]
• Digital Healthcare: Growth in the healthcare analytics segment is expected to play a key role in the digital health market, achieving a $400 billion-plus market opportunity by 2030.[xii]
• Blockchain Technology: Tokenization is likely to be a powerful catalyst for blockchain adoption, with the market for tokenized financial assets expected to grow from under $1 billion today to $4 trillion by 2030.[xiii]

Charting Disruption 2024 was produced in partnership with Wall Street Journal Custom Content. To explore the interactive website, click here or visit www.chartingdisruption.com. To download the full report, click here.

Wall Street Journal Custom Content is a unit of The Wall Street Journal Advertising Department. The Wall Street Journal news organization was not involved in the creation of this content.

About Global X ETFs

Global X ETFs was founded in 2008. For more than a decade, our mission has been empowering investors with unexplored and intelligent solutions. Our product lineup features more than 100 ETF strategies and over $40 billion in assets under management.[xiv] While we are distinguished for our Thematic Growth, Income and International Access ETFs, we also offer Core, Commodity, and Risk Management funds to suit a wide range of investment objectives. Explore our ETFs, research and insights, and more at www.globalxetfs.com.

Global X is a member of Mirae Asset Financial Group, a global leader in financial services, with more than $560 billion in assets under management worldwide.[xv] Mirae Asset has an extensive global ETF platform ranging across the US, Brazil, Canada, Colombia, Europe, Hong Kong, India, Japan, Korea, and Vietnam with over $80bn in assets under management.[xvi]

Media Contact:

Ariel Kouvaras, Sloane PR

212-446-1884

[email protected]

Risk Information

Information provided by Global X Management Company LLC.

Investing involves risk, including the possible loss of principal. Diversification does not ensure a profit nor guarantee against a loss.

This material represents an assessment of the market environment at a specific point in time and is not intended to be a forecast of future events, or a guarantee of future results. This information is not intended to be individual or personalized investment or tax advice and should not be used for trading purposes. Please consult a financial advisor or tax professional for more information regarding your investment and/or tax situation.

[i] "World Energy Transitions Outlook 2023: 1.5° Pathway," International Renewable Energy Agency (IRENA), June 2023.

[ii] "EV & Battery Quarterly Outlook: Q3 2023," Rho Motion, September 2023.

[iii] "America is Back in the Factory Business," The Wall Street Journal, April 8, 2023.

[iv] Global X ETFs estimates with information derived from "The Socioeconomic Impact of AI: Bridging the Digital Divide and Empowering Communities," Medium, August 31, 2023.

[v] Global X ETFs forecast with information derived from "Artificial Intelligence (AI) Chip Market Size to Surpass USD 227.48 BN by 2032," Precedence Research, February 8, 2023; "AMD Gains After Chipmaker Tops Estimates, Makes AI Inroads," Bloomberg, August 1, 2023.

[vi] Global X ETFs research with information derived from "Databases, Tables & Calculators by Subject," U.S. Bureau of Labor Statistics, August 30, 2023; "How Robots Will Redefine Competitiveness," Boston Consulting Group, September 23, 2015.

[vii] "Global FinTech 2023: Reimagining the Future of Finance," Boston Consulting Group, May 3, 2023.

[viii] Global X ETFs research with information derived from Macrotrends, FactSet.

[ix] "Genome Editing: Technology Overview," Evaluate Pharma. (n.d.). Accessed October 17, 2023; "Gene-Modified Cell Therapy: Technology Overview," Evaluate Pharma. (n.d.). Accessed October 17, 2023; "Gene Therapy: Technology Overview," Evaluate Pharma. Accessed October 17, 2023; "Cell Therapy: Technology Overview," Evaluate Pharma. (n.d.). Accessed October 17, 2023.

[x] "Weight-Loss Drug Market Can Hit $100 Billion, J.P. Morgan Says. That Makes Eli Lilly Stock a Big Winner," Barron's, September 7, 2023.

[xi] "Diabetes & Obesity," Diabetes U.K., September 8, 2022.

[xii] "Hospital Workforce Management Software Market," Data Bridge Market Research, May 2023; "Cardiovascular Monitoring & Diagnostic Devices WW Consensus Sales Forecasts," Evaluate Pharma. (n.d.). Accessed November 15, 2023; "Non-Invasive Monitoring Devices WW Consensus Sales Forecasts," Evaluate Pharma. (n.d.). Accessed November 15, 2023; "Diabetic Care WW Consensus Sales Forecasts," Evaluate Pharma. (n.d.). Accessed November 15, 2023; "Medical Scheduling Software Market," Insight Partners, June 2023; "Artificial Intelligence (AI) in Healthcare Market," Precedence Research, August 2022; "Electronic Health Records Market," Precedence Research, October 2022; "Revenue Cycle Management Market," Precedence Research, June 2023; "Online Doctor Consultations Revenue," Statista Market Insights, April 2023.

[xiii] "Money, Tokens, and Games: Blockchain's Next Billion Users and Trillions in Value," Citi, March 30, 2023.

[xiv] Source: Global X ETFs, as of November 2023

[xv] Source: Mirae Asset, as of November 2023

[xvi] Source: Mirae Asset, as of November 2023

SOURCE Global X Management Company LLC